Amedeo's Top 20

Amedeo Smart

Independent Medical Education

05 February 2018

Multidisciplinary Journal Club

  1. Honig LS, Vellas B, Woodward M, Boada M, et al.
    Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease.
    N Engl J Med 2018;378:321-330.

  1. Zeuzem S, Foster GR, Wang S, Asatryan A, et al.
    Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection.
    N Engl J Med 2018;378:354-369.

  2. Jakobsen GS, Smastuen MC, Sandbu R, Nordstrand N, et al.
    Association of Bariatric Surgery vs Medical Obesity Treatment With Long-term Medical Complications and Obesity-Related Comorbidities.
    JAMA 2018;319:291-301.

  3. Lau MS, Cowling BJ, Cook AR, Riley S, et al.
    Inferring influenza dynamics and control in households.
    Proc Natl Acad Sci U S A 2015.

  4. Kwong JC, Schwartz KL, Campitelli MA, Chung H, et al.
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med 2018;378:345-353.

  1. Gruntz K, Bloechliger M, Becker C, Jick SS, et al.
    Parkinson's disease and the risk of epileptic seizures.
    Ann Neurol 2018.

  2. Albers GW, Marks MP, Kemp S, Christensen S, et al.
    Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging.
    N Engl J Med 2018.

  3. Simon-Talero M, Roccarina D, Martinez J, Lampichler K, et al.
    Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.
    Gastroenterology 2018.

  4. Murata M, Odawara T, Hasegawa K, Iiyama S, et al.
    Adjunct zonisamide to levodopa for DLB parkinsonism: A randomized, double-blind phase 2 study.
    Neurology 2018.

  5. Lin JJ, Zhu VW, Yoda S, Yeap BY, et al.
    Impact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung Cancer.
    J Clin Oncol 2018.

  1. Brown SM, Azoulay E, Benoit D, Butler TP, et al.
    The Practice of Respect in the Intensive Care Unit.
    Am J Respir Crit Care Med 2018.

  2. van der Poel HG, van den Bergh RCN, Briers E, Cornford P, et al.
    Focal Therapy in Primary Localised Prostate Cancer: The European Association of Urology Position in 2018.
    Eur Urol 2018.

  3. Dong Y, Lagarde J, Xicota L, Corne H, et al.
    Neutrophil hyperactivation correlates with Alzheimer's disease progression.
    Ann Neurol 2018.

  4. Wehrum T, Beume LA, Stich O, Mader I, et al.
    Activation of disease during therapy with alemtuzumab in 3 patients with multiple sclerosis.
    Neurology 2018.

  5. Montalban X, Gold R, Thompson AJ, Otero-Romero S, et al.
    ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis.
    Mult Scler 2018.

  1. Kawkitinarong K, Suwanpimolkul G, Kateruttanakul P, Manosuthi W, et al.
    Real-Life Clinical Practice of Using the Xpert MTB/RIF Assay in Thailand.
    Clin Infect Dis 2017;64:S171-S178.

  2. Mulligan N, Best BM, Wang J, Capparelli EV, et al.
    Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV.
    AIDS 2018.

  3. Ravi D, Ghasemiesfe M, Korenstein D, Cascino T, et al.
    Associations Between Marijuana Use and Cardiovascular Risk Factors and Outcomes: A Systematic Review.
    Ann Intern Med 2018.

  4. Lee PC, Ahmed I, Loriot MA, Mulot C, et al.
    Smoking and Parkinson disease: Evidence for gene-by-smoking interactions.
    Neurology 2018.

  5. Traina TA, Miller K, Yardley DA, Eakle J, et al.
    Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer.
    J Clin Oncol 2018.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016